Jefferies analyst Glen Santangelo upgraded Viatris to Buy from Hold with a price target of $15, up from $13.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VTRS:
- Viatris put volume heavy and directionally bearish
- Viatris call volume above normal and directionally bullish
- Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division
- Viatris says emissions reduction targets approved by SBTi
- Calliditas Therapeutics enters exclusive Nefecon license agreement with Viatris